Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.97 Analyst target: $30.00 Upside: 1422.84%
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
See the full interactive analysis & chart →Informational only — not investment advice.